Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 103, Number 3, 1 September 2019

FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town?
pp. 145-151(7)
Authors: Milunović, Vibor; Mišura Jakobac, Karla; Kursar, Marin; Mandac Rogulj, Inga; Ostojić Kolonić, Slobodanka

Favourites:
ADD
Favourites:
ADD

Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph‐negative acute lymphoblastic leukemia
pp. 164-171(8)
Authors: Nagafuji, Koji; Miyamoto, Toshihiro; Eto, Tetsuya; Ogawa, Ryosuke; Okumura, Hirokazu; Takase, Ken; Kawano, Noriaki; Miyazaki, Yasuhiko; Fujisaki, Tomoaki; Wake, Atsushi; Ohno, Yuju; Kurokawa, Toshiro; Kamimura, Tomohiko; Takamatsu, Yasushi; Yokota, Shouhei; Akashi, Koichi

Favourites:
ADD

Comparison of transfusion requirements in adult patients undergoing Haploidentical or single‐unit umbilical cord blood stem cell transplantation
pp. 172-177(6)
Authors: Solves, Pilar; Sanz, Jaime; Gómez, Inés; Puerta, Rosalía; Arnao, Mario; Montoro, Juan; Piñana, José Luis; Carretero, Carlos; Balaguer, Aitana; Guerreiro, Manuel; Andreu, Rafa; Rodríguez, Rebeca; Montesinos, Pau; Jarque, Isidro; Lorenzo, José Ignacio; Carpio, Nelly; Sanz, Miguel Ángel; Sanz, Guillermo Francisco

Favourites:
ADD

Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies
pp. 178-189(12)
Authors: Levy, Michael A.; Santos, Stephanie; Kerkhof, Jennifer; Stuart, Alan; Aref‐Eshghi, Erfan; Guo, Fen; Hedley, Ben; Wong, Henry; Rauh, Michael; Feilotter, Harriet; Berardi, Philip; Semenuk, Laura; Yang, Ping; Knoll, Joan; Ainsworth, Peter; McLachlin, Catherine Meg; Chin‐Yee, Ian; Kovacs, Michael; Deotare, Uday; Lazo‐Langner, Alejandro; Hsia, Cyrus; Keeney, Mike; Xenocostas, Anargyros; Howlett, Christopher; Lin, Hanxin; Sadikovic, Bekim

Favourites:
ADD

Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005‐2015 show improved survival over time
pp. 190-199(10)
Authors: Lindström, Vesa; Hakkarainen, Katja M.; Mehtälä, Juha; Klement, Riho; Leval, Amy; Järvinen, Tiina M.

Favourites:
ADD

The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
pp. 200-207(8)
Authors: Keane, Colm; Tobin, Joshua; Gunawardana, Jay; Francis, Santiyagu; Gifford, Grace; Gabrielli, Sara; Gill, Anthony; Stevenson, William; Talaulikar, Dipti; Gould, Clare; Jain, Sanjiv; Birch, Simone; Hertzberg, Mark; Gandhi, Maher K.

Favourites:
ADD

Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients
pp. 208-214(7)
Authors: Santaliestra, Marta; Garrido, Ana; Carricondo, Maite; Bussaglia, Elena; Pratcorona, Marta; Blanco, Maria L.; Gich, Ignasi; Hoyos, Montserrat; Esquirol, Albert; García‐Cadenas, Irene; Brunet, Salut; Martino, Rodrigo; Sierra, Jorge; Nomdedéu, Josep F.

Favourites:
ADD

MiR‐137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B
pp. 215-224(10)
Authors: Huang, Yiqun; Zou, Yong; Zheng, Ruiji; Ma, Xudong

Favourites:
ADD

Pathogenic heparin‐induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry
pp. 225-233(9)
Authors: Cipok, Michal; Tomer, Aaron; Elalamy, Ismail; Kirgner, Ilya; Dror, Naama; Kay, Sigi; Deutsch, Varda R.

Favourites:
ADD

Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B‐cell non‐Hodgkin's lymphoma
pp. 234-246(13)
Authors: Wang, Li; Peng, Shaoyong; Sun, Weipeng; Liu, Xiaoxia

Favourites:
ADD

Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma
pp. 247-254(8)
Authors: Uttervall, Katarina; Borg Bruchfeld, Johanna; Gran, Charlotte; Wålinder, Göran; Månsson, Robert; Lund, Johan; Gahrton, Gösta; Alici, Evren; Nahi, Hareth

Favourites:
ADD

Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials
pp. 255-267(13)
Authors: Straka, Christian; Knop, Stefan; Vogel, Martin; Müller, Jürgen; Kropff, Martin; Metzner, Bernd; Langer, Christian; Sayer, Herbert; Jung, Wolfram; Dürk, Heinz A.; Salwender, Hans; Wandt, Hannes; Bassermann, Florian; Gramatzki, Martin; Rösler, Wolf; Wolf, Hans‐Heinrich; Brugger, Wolfram; Fischer, Thomas; Liebisch, Peter; Engelhardt, Monika; Einsele, Hermann

Favourites:
ADD

Fatal disseminated enterovirus infection in a patient with follicular lymphoma undergoing obinutuzumab maintenance therapy
pp. 268-271(4)
Authors: Heger, Jan‐Michel; Eichenauer, Dennis A.; Kasper, Philipp; Böll, Boris; Shimabukuro‐Vornhagen, Alexander; Kochanek, Matthias

Favourites:
ADD

“Variant‐specific discrepancy when quantitating BCR‐ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key?
pp. 272-273(2)
Authors: Bernardi, Simona; Bonifacio, Massimiliano; Iurlo, Alessandra; Zanaglio, Camilla; Tiribelli, Mario; Binotto, Gianni; Abruzzese, Elisabetta; Russo, Domenico

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more